Price $0.41 |
Market Cap
63M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
7.63
|
Dividend %
-
|
|
P/CF
2.8
|
P/FCF
13.2
|
Op. Cash Flow
12.1K
|
FCF
0.0
|
|
Op. Margin
-347.90%
|
Net Margin
-369.60%
|
ROE
215.70%
|
ROI
-
|
|
ROA
-163.30%
|
EPS Growth
29.00%
|
Current Ratio
0.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vycor Medical Inc (VYCO) | $0.30 | - | - | 3.8M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| iCAD Inc (ICAD) | $3.65 | - | - | 64.7M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.37 | - | - | 17.2M | Strong Buy |
| Endo International PLC (ENDP) | $8.72 | - | - | 2.49B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
